Presentation Information

[1S14a-1]Multi-Modality Strategy for Creating Innovative Drugs

Narihiro Toda (Modality Research Laboratories I, Research Function, R&D Division, Daiichi Sankyo Co., Ltd.)

Login required to view

Login is required to view some content.

Comment

To browse or post comments, you must log in.Log in